Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PFIZER INC Declaration of Voting Results & Voting Rights Announcements 2013

Apr 29, 2013

29831_rns_2013-04-29_19d1eb4c-ad58-4d54-a93b-d1503681095c.zip

Declaration of Voting Results & Voting Rights Announcements

Open in viewer

Opens in your device viewer

8-K 1 pf8k425v.htm PFIZER INC. 8-K Pfizer Inc. 8K -

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): April 25, 2013

PFIZER INC. (Exact name of registrant as specified in its charter)

Delaware 1-3619 13-5315170
(State or other Jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.)
235 East 42nd Street New York, New York (Address of principal executive offices) 10017 (Zip Code)

Registrant's telephone number, including area code:

(212) 733-2323 Not Applicable (Former Name or Former Address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions:

[ ] Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.07
(a) Pfizer’s Annual Meeting of Shareholders was held on April 25, 2013.
(b) Shareholders voted on the matters set forth below.

1. The nominees for election to the Board of Directors were elected, each for a one-year term, based upon the following votes:

Nominee Votes For Votes Against Abstentions Broker Non-Votes
Dennis A. Ausiello 5,032,447,443 38,616,895 20,201,009 883,570,086
M. Anthony Burns 4,972,937,743 97,172,501 21,130,781 883,570,086
W. Don Cornwell 4,831,343,462 239,407,979 20,517,594 883,570,086
Frances D. Fergusson 5,020,361,208 54,704,511 16,174,904 883,570,086
William H. Gray, III 4,942,943,318 127,740,786 20,583,253 883,570,086
Helen H. Hobbs 5,039,913,072 35,997,819 15,324,826 883,570,086
Constance J. Horner 4,972,870,242 97,872,829 20,519,195 883,570,086
James M. Kilts 4,966,911,968 107,679,895 16,674,571 883,570,086
George A. Lorch 4,973,862,443 96,622,604 20,781,448 883,570,086
Suzanne Nora Johnson 5,002,043,649 68,361,687 20,865,030 883,570,086
Ian C. Read 4,858,886,856 194,188,507 38,195,316 883,570,086
Stephen W. Sanger 5,038,551,371 36,156,867 16,562,764 883,570,086
Marc Tessier-Lavigne 5,047,450,464 27,910,962 15,904,917 883,570,086

2. The proposal to ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for 2013 was approved based upon the following votes:

Votes for approval 5,876,660,641
Votes against 77,136,852
Abstentions 21,041,622
Broker Non-Votes N/A

3. The proposal to approve, on an advisory basis, the compensation of the Company's Named Executive Officers was approved based upon the following votes:

Votes for approval 4,830,867,107
Votes against 222,313,840
Abstentions 38,052,133
Broker-Non Votes 883,570,086

4. The shareholder proposal regarding executive equity retention was not approved based upon the following votes:

Votes for approval 1,434,132,567
Votes against 3,605,035,969
Abstentions 52,043,969
Broker-Non Votes 883,570,086

5. The shareholder proposal regarding action by written consent was not approved based upon the following votes:

Votes for approval 2,385,502,317
Votes against 2,648,133,285
Abstentions 57,629,331
Broker non-votes 883,570,086
(c) Not applicable
(d) Not applicable.

SIGNATURE

Under the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the authorized undersigned.

PFIZER INC.
Dated: April 29, 2013 By: /s/ Matthew Lepore Matthew Lepore
Title: Vice President & Corporate Secretary